Alarcón-Moreno, José Carlos
Flores-Muñoz, Mónica
Blázquez-Morales, María Sobeida L.
García-Rivera, Miguel Eric
Rodríguez-Alba, Juan Carlos
Castro-López, Claudio Rafael
Nachón-García, Francisco Javier
Muñoz-Muñoz, Víctor Hugo
Nachón-García, María Gabriela.
Article History
Received: 1 May 2024
Accepted: 30 July 2024
First Online: 4 August 2024
<!--Emphasis Type='Bold' removed-->Declarations
:
: This study was approved by the research ethics committee of the Institute of Health Science from Universidad Veracruzana and the ethical committee of Dr. Rafael Lucio Hospital Xalapa, Veracruz. México.(F-011/2018-F.10/2022.) The registration date for the clinical trial on . received code of (ISRCTN 14092381. September 13º 2023. Retrospectively Registered<b>)</b> All participants in this research were given an informed consent form. The patients who agreed to participate signed the requirement sheet, a procedure approved by the Ethics and Investigation Committee. Committee Names: “Comité de Ética en Investigacion del Instituto de Ciencias de la Salud de la Universidad Veracruzana”. COBIOETICA-30-CEI-001-20180131. References number (Nº 011/2018 - Nº010/2022). “Centro de Alta Especialidad “Dr. Rafael Lucio” Subdirección de Enseñanza y Capacitación. Departamento de Investigación”. COFEPRIS 16CI 30087028. Reference Number (Nº48/18).
: The participants who made up the samples signed the informed consent voluntarily, accepting their participation, publication of the results and, where appropriate, intraoral photographs that do not allow their identification and the authors were committed to safe confidentiality.
: “Not applicable”.
: The authors declare no competing interests.